Search

everythinglearnresearchcommunity

for

Search:↓

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Adequate steroid treatment needed to limit bone loss in PMR patients.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

The document is a detailed medical reference on skin and genetic disorders.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Fisetin may help treat psoriasis and reduce skin inflammation.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The document lists various dermatology topics, treatments, and diagnostic methods.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Minoxidil and photobiomodulation together improve hair growth better than minoxidil alone.

New treatment improves male hair loss.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Latanoprost can make eyelashes longer, thicker, and darker.